Hendriks D, Soons J, Scharpé S, Wevers R, van Sande M, Holmquist B
Department of Medical Biochemistry, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.
Clin Chim Acta. 1988 Mar 15;172(2-3):253-60. doi: 10.1016/0009-8981(88)90331-2.
The enzyme responsible for the post-translational modification of creatine kinase-MM isoenzyme was purified from human plasma. The enzymatic activity of this enzyme (modifying protein) on the synthetic substrates hippuryl-L-arginine, hippuryl-L-lysine, 3-(2-furylacryloyl)-L-arginine and 3-(2-furylacryloyl)-L-alanyl-L-lysine and the ratio of activities on these substrates are in good agreement with the enzymatic activity of the human serum carboxypeptidase N. The effect of metal ions, chelating agents, proteolytic inhibitors and carboxypeptidase N inhibitor could not differentiate the modifying protein from human serum carboxypeptidase N. Affinity chromatography on Concanavalin-A-Sepharose demonstrated the glycoprotein nature of the modifying protein. The difference in molecular weight observed between modifying protein and carboxypeptidase N can be explained by known instability characteristics and the influence of proteolytic enzymes during purification. Double immunodiffusion analysis with purified antiserum to human carboxypeptidase N confirmed the identity of the modifying protein and carboxypeptidase N.
负责肌酸激酶-MM同工酶翻译后修饰的酶是从人血浆中纯化得到的。该酶(修饰蛋白)对合成底物马尿酸-L-精氨酸、马尿酸-L-赖氨酸、3-(2-呋喃丙烯酰)-L-精氨酸和3-(2-呋喃丙烯酰)-L-丙氨酰-L-赖氨酸的酶活性以及这些底物上的活性比与人类血清羧肽酶N的酶活性高度一致。金属离子、螯合剂、蛋白水解抑制剂和羧肽酶N抑制剂的作用无法区分该修饰蛋白与人类血清羧肽酶N。伴刀豆球蛋白A-琼脂糖亲和层析证明了该修饰蛋白的糖蛋白性质。修饰蛋白与羧肽酶N之间观察到的分子量差异可以用已知的不稳定性特征以及纯化过程中蛋白水解酶的影响来解释。用纯化的抗人羧肽酶N抗血清进行的双向免疫扩散分析证实了修饰蛋白与羧肽酶N的同一性。